Tzu-Fei Wang Selected Research

Member 1 Subfamily B ATP Binding Cassette Transporter

3/2022	Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults.
1/2022	Hemorrhage Risk Among Patients With Breast Cancer Receiving Concurrent Direct Oral Anticoagulants With Tamoxifen vs Aromatase Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tzu-Fei Wang Research Topics

Disease

58	Neoplasms (Cancer) 04/2024 - 01/2012
31	Hemorrhage 04/2024 - 02/2018
28	Venous Thromboembolism 04/2024 - 02/2018
21	Thrombosis (Thrombus) 04/2024 - 12/2016
7	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023 - 01/2020
6	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 10/2018
5	Thrombocytopenia (Thrombopenia) 10/2023 - 10/2018
4	Thromboembolism 04/2024 - 12/2019
4	Obesity 01/2023 - 09/2015
3	Upper Extremity Deep Vein Thrombosis 12/2023 - 01/2021
3	Atrial Fibrillation 11/2023 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2020
3	Pulmonary Embolism 01/2022 - 04/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 08/2018
2	Hemophilia A (Haemophilia) 12/2023 - 12/2018
2	Stroke (Strokes) 11/2023 - 01/2022
2	Thrombophilia 11/2023 - 01/2021
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 12/2018
2	Multiple Myeloma 11/2016 - 02/2014
1	Lymphoma (Lymphomas) 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022
1	Postthrombotic Syndrome 04/2022
1	Factor V Deficiency 01/2022
1	Morbid Obesity 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Chronic Disease (Chronic Diseases) 11/2021
1	Disseminated Intravascular Coagulation 12/2020
1	Leukemia 12/2020

Drug/Important Bio-Agent (IBA)

39	AnticoagulantsIBA 04/2024 - 09/2015
13	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023 - 02/2018
9	apixabanIBA 04/2024 - 12/2018
6	edoxabanIBA 12/2021 - 02/2018
5	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 02/2018
4	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2022
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2016
3	Vitamin K FDA Link 01/2022 - 01/2017
2	RivaroxabanIBA 04/2024 - 05/2021
2	AntigensIBA 04/2024 - 01/2020
2	Prothrombin (Factor II)IBA 01/2024 - 11/2023
2	factor V LeidenIBA 01/2024 - 11/2023
2	Factor Xa InhibitorsIBA 01/2023 - 01/2021
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2023 - 01/2023
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 12/2021 - 01/2017
2	ORALIT (ORS)IBA 12/2021 - 11/2021
2	Asparaginase (Elspar)FDA Link 12/2020 - 01/2020
2	AntithrombinsIBA 01/2020 - 12/2019
1	Chimeric Antigen ReceptorsIBA 04/2024
1	fibrinogen gamma'IBA 11/2023
1	SerpinsIBA 11/2023
1	serum P-component (CIt)IBA 10/2023
1	Thrombopoietin ReceptorsIBA 10/2023
1	C-Reactive ProteinIBA 01/2023
1	LigandsIBA 01/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 12/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2022
1	Troponin T (Troponin T1)IBA 07/2022
1	Trinitrotoluene (TNT)IBA 07/2022
1	pro-brain natriuretic peptide (1-76)IBA 07/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2022
1	Cytochrome P-450 CYP3AIBA 03/2022
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 03/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2022
1	Verapamil (Calan)FDA LinkGeneric 03/2022
1	Aromatase InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Hemostatics (Antihemorrhagics)IBA 12/2020
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2020
1	pegaspargase (Oncaspar)FDA Link 09/2020
1	AgglutininsIBA 01/2020

Therapy/Procedure

24	Therapeutics 04/2024 - 06/2019
15	Drug Therapy (Chemotherapy) 11/2023 - 01/2012
7	Catheters 12/2023 - 01/2021
6	Central Venous Catheters 12/2023 - 10/2018
2	Platelet Transfusion (Blood Platelet Transfusions) 10/2023 - 12/2020
2	Duration of Therapy 08/2018 - 02/2018
1	Contraindications 01/2024
1	Stents 12/2023
1	Drug Tapering 10/2023
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2023